Immune response confirmed in stand-alone influenza vaccine and combination vaccine with a potential path forward for both
The MicroGEM Saliva test is the first point of care PCR saliva test for Covid-19 delivering results in minutes
This marks an expansion of the companies' existing collaboration and further validates the use of Albumedix Recombumin rHA products in the manufacturing process and final formulation of critical vaccines
Momelotinib complements GSK’s existing expertise in haematology, with Sierra Oncology anticipating US regulatory submission in Q2 this year and EU submission in the second half of 2022
The total investment is in the region of Rs 200 crore
The peptide-based vaccine induces a t cell-dependent response
Nuvaxovid is the first protein-based Covid-19 vaccine authorized for use in Switzerland
This could be a game-changer for the prevention of the disease; seeing more doses of the life-saving jab reach more girls
Pharmapack trends are a key barometer of global device and packing opportunities in 2022
Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation
Subscribe To Our Newsletter & Stay Updated
